Louis Vaickus
Presidente presso Akta Pharmaceutical Development LLC
Profilo
Louis Vaickus is the President of Akta Pharmaceutical Development LLC.
Prior to this, he held several positions in the pharmaceutical industry, including Director-Medical Marketing at EMD Serono, Inc. from 1993 to 1998, Senior Vice President-Medical Affairs at Sumitomo Pharma America, Inc. from 1998 to 2002, and Chief Medical Officer at Tolerx, Inc. from 2002 to 2011.
He also served as Chief Medical Officer at Invivo Therapeutics Holdings Corp.
and Verastem, Inc. Dr. Vaickus received a graduate degree from Loyola University of Chicago.
Posizioni attive di Louis Vaickus
Società | Posizione | Inizio |
---|---|---|
Akta Pharmaceutical Development LLC
Akta Pharmaceutical Development LLC Pharmaceuticals: MajorHealth Technology Akta Pharmaceutical Development LLC is an open-architecture business consortium that partners with biopharmaceutical companies, private investment firms, and academic and government clients to facilitate the development of meaningful products, including new chemical entities, biosimilars, biologicals, cell therapies, beneficial bacteria, foods, diagnostics, medical tools, and devices. The private company is based in Hingham, MA. The company offers services in clinical development, leadership, regulatory affairs, operations, CRO governance, technology, knowledge transfer, manufacturing, marketing, and vendor management. | Presidente | - |
Precedenti posizioni note di Louis Vaickus
Società | Posizione | Fine |
---|---|---|
VERASTEM, INC. | Direttore Tecnico/Scientifico/R&S | 15/04/2016 |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 19/12/2011 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Direttore Tecnico/Scientifico/R&S | 01/07/2002 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Vendite & Marketing | - |
INVIVO THERAPEUTICS HOLDINGS CORP. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Louis Vaickus
Loyola University of Chicago | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
VERASTEM, INC. | Health Technology |
Aziende private | 4 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Akta Pharmaceutical Development LLC
Akta Pharmaceutical Development LLC Pharmaceuticals: MajorHealth Technology Akta Pharmaceutical Development LLC is an open-architecture business consortium that partners with biopharmaceutical companies, private investment firms, and academic and government clients to facilitate the development of meaningful products, including new chemical entities, biosimilars, biologicals, cell therapies, beneficial bacteria, foods, diagnostics, medical tools, and devices. The private company is based in Hingham, MA. The company offers services in clinical development, leadership, regulatory affairs, operations, CRO governance, technology, knowledge transfer, manufacturing, marketing, and vendor management. | Health Technology |
- Borsa valori
- Insiders
- Louis Vaickus